Table 2.
Characteristic | No intervention (N = 301)∗ Mean (SD) |
Intervention (N = 110)∗ Mean (SD) |
t test P value† |
---|---|---|---|
Total N | 25.5 (11.6) | 31.6 (16.6) | <.001 |
Dementia or cognitive impairment | 79.3% (10.7%) | 81.1% (10.6%) | .133 |
Any appropriate indication for antipsychotic | 33.3% (18.1%) | 37.3% (19.1%) | .044 |
Physical aggression | 10.4% (9.7%) | 12.2% (9.3%) | .089 |
Verbal aggression | 15.5% (12.5%) | 16.4% (12.6%) | .511 |
Wandering | 8.5% (8.5%) | 10.3% (8.6%) | .056 |
Reject or resist care | 17.1% (15.5%) | 18.8% (15.4%) | .317 |
Delusions | 12.2% (14.1%) | 14.2% (15.2%) | .204 |
Hallucinations | 3.9% (5.4%) | 4.8% (5.3%) | .134 |
Delirium | 14.9% (15.6%) | 18.3% (18.0%) | .059 |
Recent history of fall | 45.6% (14.0%) | 45.0% (11.7%) | .692 |
Unsteady gait | 56.1% (16.5%) | 56.2% (17.5%) | .938 |
Parkinson's disease or Lewy body dementia | 10.4% (7.5%) | 11.8% (6.6%) | .097 |
Parkinson's disease | 9.9% (7.5%) | 11.2% (6.5%) | .107 |
Lewy body dementia | 3.2% (4.3%) | 3.3% (3.7%) | .912 |
Diabetes, hyperlipidemia, or hypertension | 93.6% (5.8%) | 93.5% (5.5%) | .881 |
Diabetes | 37.8% (13.8%) | 33.8% (10.6%) | .006 |
Hyperlipidemia | 5.9% (6.9%) | 4.3% (4.5%) | .020 |
Hypertension | 89.5% (7.8%) | 89.7% (7.6%) | .810 |
Antipsychotic use | 17.7% (10.4%) | 20.7% (10.6%) | .010 |
Antipsychotic use at excessive dose | 2.3% (3.9%) | 2.0% (3.0%) | .442 |
Anticholinergic use | 35.9% (12.0%) | 36.1% (10.9%) | .912 |
Non-antipsychotic anticholinergic use | 28.4% (11.4%) | 28.2% (9.9%) | .897 |
Abbreviations: IA-ADAPT, Improving Antipsychotic Appropriateness in Dementia Patients program; SD, standard deviation.
Total number of facilities in modeling data file in March 2012, N = 426 (114 with intervention); seven facilities were not included in the comparison because of a low number of eligible residents (<10 residents). Data are means of facility-level resident counts and prevalence data rather than a summary of individual-level data.
Significant P values shown in bold.